Navigation Links
UCSF Launches Nationwide Clinical Trial Matching Web Site for Breast Cancer

SAN FRANCISCO, Oct. 14 /PRNewswire/ -- The University of California, San Francisco (UCSF) Center of Excellence for Breast Cancer Care today launched, a free, non-profit, clinical trial matching service that provides nationwide information for individuals diagnosed with or at risk for breast cancer.

To view the Multimedia News Release, go to: is the only clinical trial matching service dedicated exclusively to breast cancer, with an online database that includes information about clinical trials taking place at more than 1100 medical facilities across the country. The site is an outgrowth of a successful regional pilot initiated by the UCSF Carol Franc Buck Breast Care Center, the National Cancer Institute (NCI) and patient advocates. The nationwide launch of is made possible by a grant from The Safeway Foundation, the philanthropic arm of Safeway, Inc.

" is an exciting, win-win development for the breast cancer community," said Laura Esserman, M.D., Director of the UCSF Center of Excellence for Breast Cancer Care and the UCSF Carol Franc Buck Breast Care Center. "Every advance in our understanding and treatment of breast cancer has come from clinical trial results. The more we can empower our patients to find out about and participate in trials, the faster we will be able to complete trials, and the sooner this new knowledge will translate into better care and outcomes for all patients."

By making information about trials easy to find, hopes to make consideration of clinical trial participation the norm rather than the exception. By helping patients find and evaluate trials for which they may be eligible, and by encouraging and facilitating patient enrollment in trials, intends to increase the rate at which new treatments and procedures are made available to all breast cancer patients, as well as those at heightened risk for developing the disease.

"I made the decision to enroll in a clinical trial because I wanted to explore all of my treatment options," said breast cancer survivor and user Isabel Hemming of Los Angeles, California. "Through, it was easy to find several trials that were seeking women with the type of breast cancer that I was diagnosed with, and -- after talking to my doctor -- I was able to identify one that I was eligible for. I hope that my participation in the trial may one day result in improved treatment for other women like me." users enter a detailed health history, which matches them to trials that are specific to their personal health situation. Information on whom to contact for further discussion about a trial and additional criteria for enrollment is also provided. Individuals can use on a one-time basis or store their health history on secure servers for continual matching to newly listed trials. Information stored on is never sold or shared with external parties.

According to the Clinical Research Roundtable at the Institute of Medicine, very few patients are currently aware that they are eligible for participation in research studies, making recruitment challenging for trial sites.(1) By helping individuals evaluate trials as a routine option for care, hopes to increase the rate at which new treatments and procedures are developed and made available to individuals at all stages of their disease.

About operates as an independent non-profit corporation. was initially co-developed as a regional pilot by the National Cancer Institute and the University of California, San Francisco Center of Excellence for Breast Cancer Care (COE-BCC), an integral program of the UCSF Carol Franc Buck Breast Care Center, and a core program of the UCSF National Center of Excellence in Women's Health and the UCSF Helen Diller Family Comprehensive Cancer Center. With the success of the pilot, was incorporated as a separate non-profit corporation dedicated to the continuing delivery of this service.

For further information, visit the site at

About Breast Cancer

According to the American Cancer Society's Breast Cancer Facts & Figures 2007-2008, breast cancer is a progressive and potentially deadly disease that will affect about 182,460 women in 2008. About 40,480 women will die from breast cancer this year, and there are about 2.5 million breast cancer survivors in the United States. Additional research is critical and necessary to ensure that the millions affected by or at risk for breast cancer receive the proper treatment they need, according to ACS.

About the University of California, San Francisco

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For more information on UCSF, visit

(1) "Central Challenges Facing the National Clinical Research Enterprise." Journal of the American Medical Association, Vol 289, No. 10. March 12, 2003.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
2. UPMC Health Plan Launches New Personal Health Record
3. Launches Video Contest for Young Directors
4. Academy of General Dentistry Launches Campaign to Focus on Tooth Erosion
5. Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program
6. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
7. Mannatech Launches Phase One of New Sales and Training Tools
8. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
9. Actavis Launches Carvedilol Tablets in the U.S.
10. MedQuist Re-launches New, Improved Web Site
11. Elsevier launches new journal: Stem Cell Research
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced that ... Business Awards under the New Products and Services category for its innovative product ... management software that helps labs organize data and track samples with storage ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, ... a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program ... as a finalist in the category of Digital Solutions for its innovative, industry-leading ...
(Date:12/1/2015)... ... 01, 2015 , ... TCS Healthcare Technologies (TCS), a leading ... arenas, is pleased to announce that VIP Care Services, a Caprock Health Group ... ACUITY Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015  Eyeon Therapeutics has ... dry eye treatments based on a charged hydrophilic ... delivery CDMO.  The product has been shown to ... previously published.  Mark Mitchnick , MD, CEO ... protection to additional polymers in conjunction with a ...
(Date:12/1/2015)... , December 1, 2015 --> ... report "Immunotherapy Drugs Market by Type of Drug (Monoclonal Antibodies, ... Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020", ... to reach USD 73,529.2 Million by 2020 from USD 40,281.6 ... to 2020. Browse 37 ...
(Date:12/1/2015)... HERTFORDSHIRE, England , BANGALORE, India ... 2015  Mylan N.V. (NASDAQ, TASE: MYL) today announced ... upon regulatory approval and for developing country markets funded ... + Lamivudine 300 mg + Efavirenz 400 mg) for ... Clinton Health Access Initiative (CHAI) to develop TLE400. The ...
Breaking Medicine Technology: